|
1 |
Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals
Enthalten in Nature medicine 18.10.2022: 1-9
|
|
|
2 |
Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases
Altenburg, Arwen F.. - Ludwig-Maximilians-Universität München, 2014
|
|
|
|
3 |
An autotransporter display platform for the development of multivalent recombinant bacterial vector vaccines
Enthalten in Microbial cell factories Bd. 13, 25.11.2014, Nr. 1, date:12.2014: 1-15
|
|
|
|
4 |
Effects of pre-existing orthopoxvirus-specific immunity on the performance of Modified Vaccinia virus Ankara-based influenza vaccines
Enthalten in Scientific reports Bd. 8, 24.4.2018, Nr. 1, date:12.2018: 1-14
|
|
|
|
5 |
Influenza in long-term Dutch travelers in the tropics: symptoms and infections
Enthalten in BMC infectious diseases Bd. 16, 16.4.2016, Nr. 1, date:12.2016: 1-6
|
|
|
|
6 |
Matrix-M™ adjuvant enhances immunogenicity of both protein- and modified vaccinia virus Ankara-based influenza vaccines in mice
Enthalten in Immunologic research Bd. 66, 28.3.2018, Nr. 2, date:4.2018: 224-233
|
|
Administration
